Our analysis showed that the expression level of UGT2B4 in breast cancer tumors was significantly lower than that in normal tissues, while UGT2B4 was significantly higher in tumors than in normal prostate cancer tissues (Figure 5A and Supplementary Figure S3). This evidence concerns the gene UGT2B4 and prostate carcinoma.